Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
07 09 2020
07 09 2020
Historique:
received:
20
05
2020
accepted:
20
05
2020
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
23
9
2020
Statut:
epublish
Résumé
The pandemic caused by Novel Coronavirus SARS-CoV-2 shows its devastating effects all over the world. The American and the European countries are the worst-hit by this COVID-19 pandemic. However, most of the African countries excepting a few are less affected by this virus as far as the number of cases and deaths are concerned. The correspondence proposes that just like the abnormal haemoglobins HbS and HbC are found to provide immunity to the African populations against infectious diseases such as Plasmodium falciparum malaria The possibility of these abnormal haemoglobins offering certain protection against the Novel Coronavirus infection in these populations needs to be explored.
Identifiants
pubmed: 32921745
doi: 10.23750/abm.v91i3.9872
pmc: PMC7717003
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Letter
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2020023Références
Mediterr J Hematol Infect Dis. 2012;4(1):e2012065
pubmed: 23170194
Malar J. 2011 May 24;10:144
pubmed: 21609473
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7051-4
pubmed: 25941403
Br Med J. 1954 Feb 6;1(4857):290-4
pubmed: 13115700
Nature. 2005 Jun 23;435(7045):1117-21
pubmed: 15973412
Int J Antimicrob Agents. 2020 Apr;55(4):105932
pubmed: 32145363